Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study.
Fernández-Rodríguez CM, Morillas RM, Masnou H, Navarro JM, Bárcena R, González JM, Martín-Martín L, Poyato A, Miquel-Planas M, Jorquera F, Casanovas T, Salmerón J, Calleja JL, Solà R, Alonso S, Planas R, Romero-Gomez M. Fernández-Rodríguez CM, et al. Among authors: poyato a. Gastroenterol Hepatol. 2014 Jan;37(1):1-8. doi: 10.1016/j.gastrohep.2013.10.005. Epub 2013 Dec 17. Gastroenterol Hepatol. 2014. PMID: 24360571 Clinical Trial.
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world.
Pérez AB, Chueca N, García-Deltoro M, Martínez-Sapiña AM, Lara-Pérez MM, García-Bujalance S, Aldámiz-Echevarría T, Vera-Méndez FJ, Pineda JA, Casado M, Pascasio JM, Salmerón J, Alados-Arboledas JC, Poyato A, Téllez F, Rivero-Juárez A, Merino D, Vivancos-Gallego MJ, Rosales-Zábal JM, García F; GEHEP-004 Study Group. Pérez AB, et al. Among authors: poyato a. J Hepatol. 2019 Nov;71(5):876-888. doi: 10.1016/j.jhep.2019.06.022. Epub 2019 Jul 4. J Hepatol. 2019. PMID: 31279901
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.
Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, Popping S, Sfalcin JA, Parczewski M, Sarrazin C, de Salazar A, Fuentes A, Sayan M, Quer J, Kjellin M, Kileng H, Mor O, Lennerstrand J, Fourati S, Di Maio VC, Chulanov V, Pawlotsky JM, Harrigan PR, Ceccherini-Silberstein F, Garcia F; SHARED Collaborators. Howe AYM, et al. JHEP Rep. 2022 Feb 24;4(5):100462. doi: 10.1016/j.jhepr.2022.100462. eCollection 2022 May. JHEP Rep. 2022. PMID: 35434589 Free PMC article.
Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Rodríguez-Perálvarez M, Guerrero M, Barrera L, Ferrín G, Álamo JM, Ayllón MD, Artacho GS, Montero JL, Briceño J, Bernal C, Padillo J, Marín-Gómez LM, Pascasio JM, Poyato A, Gómez-Bravo MA, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: poyato a. Transplantation. 2018 Dec;102(12):2056-2064. doi: 10.1097/TP.0000000000002270. Transplantation. 2018. PMID: 29757893
Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
Pérez P, Rodríguez-Perálvarez M, Guerrero L, González V, Sánchez R, Centeno M, Poyato A, Briceño J, Sánchez-Frías M, Montero JL, De la Mata M. Pérez P, et al. Among authors: poyato a. PLoS One. 2017 Apr 12;12(4):e0175010. doi: 10.1371/journal.pone.0175010. eCollection 2017. PLoS One. 2017. PMID: 28403219 Free PMC article.
mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence.
Guerrero M, Ferrín G, Rodríguez-Perálvarez M, González-Rubio S, Sánchez-Frías M, Amado V, Pozo JC, Poyato A, Ciria R, Ayllón MD, Barrera P, Montero JL, de la Mata M. Guerrero M, et al. Among authors: poyato a. Int J Mol Sci. 2019 Jan 15;20(2):336. doi: 10.3390/ijms20020336. Int J Mol Sci. 2019. PMID: 30650598 Free PMC article.
Everolimus is safe within the first month after liver transplantation.
Rodríguez-Perálvarez M, Pérez-Medrano I, Guerrero-Misas M, González V, Poyato A, Barrera P, Ferrín G, Pozo JC, Sánchez-Frías M, Ciria R, Briceño J, Montero JL, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: poyato a. Transpl Immunol. 2015 Oct;33(2):146-51. doi: 10.1016/j.trim.2015.09.002. Epub 2015 Sep 24. Transpl Immunol. 2015. PMID: 26392195
Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ response.
Páez-Vega A, Poyato A, Rodriguez-Benot A, Guirado L, Fortún J, Len O, Abdala E, Fariñas MC, Cordero E, de Gracia C, Hernández D, González R, Torre-Cisneros J, Cantisán S; Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016); Spanish Renal Disease Network (REDinREN, RD16/0009). Páez-Vega A, et al. Among authors: poyato a. Antiviral Res. 2018 Jul;155:97-105. doi: 10.1016/j.antiviral.2018.05.006. Epub 2018 May 18. Antiviral Res. 2018. PMID: 29782877 Free article.
[Prognostic factors associated with postoperative complications in liver transplant].
Rodríguez-Ariza A, Monrobel A, Martínez-Galisteo E, Alicia Padilla C, Bárcena JA, Fraga E, Costán G, Barrera P, Poyato A, Montero JL, López-Cillero P, Muntané J, de la Mata M. Rodríguez-Ariza A, et al. Among authors: poyato a. Rev Esp Enferm Dig. 2008 Mar;100(3):129-38. doi: 10.4321/s1130-01082008000300002. Rev Esp Enferm Dig. 2008. PMID: 18416637 Free article. Spanish.
16 results